MEK-InhibitorenRare
Used by 1 of 1.803 companies (0.1%)
startupVerified
Atriva Therapeutics
- Location
- Industry
- biopharmaceutical / antiviral / respiratory
- Founded
- 2015
- Employees
- 11-50
- Total funding
- €10.2 Mio
Tech-Stack
Tech stack in context
Each entry is benchmarked against all 1.803 companies in the dataset. Rare items first — those are the more interesting choices.
RareUncommonCommonMainstream
klinische StudienRare
Used by 8 of 1.803 companies (0.4%)
GMPRare
Used by 9 of 1.803 companies (0.5%)
In context
Raw numbers say little — here's how Atriva Therapeutics compares to its industry and city.
Funding position
Top 52%
More funding than 48% of all companies with reported funding.
Industry median: €10.2 Mio
Similar companies
Similar companies
Similar stack
At least 2 shared technologies
Same location
Local tech ecosystem
Consulting on this stack
Working with a similar stack?
We help companies like this build data-driven platforms — from AI research to production deploy.